Department of Cardiovascular Surgery, Houston Methodist, The Woodlands, Texas, US.
Methodist Debakey Cardiovasc J. 2024 May 16;20(3):65-67. doi: 10.14797/mdcvj.1394. eCollection 2024.
Anticoagulation has been the standard therapy for treating pulmonary embolism. However, newly developed pharmacological and interventional treatment options have been shown to provide benefit for certain patient populations, depending on how they present. This column highlights the use of massive pulmonary embolism risk stratification in determining the presence of cor pulmonale and offers several key points to remember when caring for patients with a pulmonary embolism.
抗凝一直是治疗肺栓塞的标准疗法。然而,新开发的药理学和介入治疗选择已被证明可为某些患者群体提供益处,具体取决于他们的表现。本专栏重点介绍了使用大规模肺栓塞风险分层来确定肺心病的存在,并提供了在护理肺栓塞患者时需要记住的几个要点。